FDA Antimicrobial Development Draft Guidances Withdrawn Under Rejuvenation Initiative
This article was originally published in Pharmaceutical Approvals Monthly
FDA says the 13 guidances are out of date and of no use to industry; a number of others covering various topics also will be revised or finalized.
You may also be interested in...
FDA’s Center for Drug Evaluation and Research plans to publish more than 50 new and revised draft guidances this calendar year.
Commissioner Robert Califf wants Woodcock to improve food operations and processes, but lawmakers question whether she is the best overseer for the area.
The bill would allow for tentative interchangeable approvals, as well as shared first interchangeable exclusivity for multiple first filers.